The technology is said to be twice as accurate at predicting five-year cancer risk compared to current risk assessment methods.

Experts are hopeful their device can address some of the shortcomings of currently used shielding methods. 

The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Considering the often-aggressive nature of interval breast cancer, the findings could represent a significant step toward improving patient outcomes, authors of a new research paper suggest.

The American Registry Of Radiologic Technologists says the new offering addresses growing demand for magnetic resonance imaging.

Renowned cardiologist Eric J. Topol, MD, and Harvard AI authority Pranav Rajpurkar, PhD, shared their thoughts in a commentary published by the RSNA.

By viewing large-language AI models through the lens of harm-reduction thinking, healthcare adopters can cultivate a responsible, ethical and optimal integration of the technology. 

Hospitals are awarded Honor Roll points if they rank in one or more of the 15 specialties that U.S. News evaluates, and in one or more of the 22 procedures or conditions for patient outcomes.

The issue, associated with calcification, can make these devices less effective over time. The Heart Rhythm Society shared a detailed analysis of the situation.